Swiss Startup Signs on with Novo Nordisk to Discover Obesity Treatments
The Swiss startup EraCal Therapeutics has signed a research partnership with the Danish pharmaceutical giant…
The Swiss startup EraCal Therapeutics has signed a research partnership with the Danish pharmaceutical giant…
A food supplement made from bacteria, developed by a Belgian research group, has improved symptoms…
Saniona, a biotech focused on ion channel research, plans to test its lead candidate in…
Boehringer Ingelheim starts two new Phase I trials with drugs intended to treat type 2…
What do you think when you hear the word ‘lipid’? I bet your thoughts include…
Apart from boasting big players in the space of metabolic diseases including Novo Nordisk and…
A whole new avenue to human health and disease could soon be accessible, thanks to…
The French biotech startup TargEDys has extended its series A funding initiated in April 2016…
Novartis is initiating Phase II trials with an antibody licensed from German biotech MorphoSys that…
Eternygen has received €8M in a Series A round led by Epidarex Capital that will be…
Researchers at King's College London have found a new link between gut microbiome diversity (or,…
Ablynx – the Belgian Nanobody biotech (which uses monoclonal antibodies of Alpacas) has entered a…